
Former CEO of Novartis Pharmaceuticals, David Epstein, has had a busy start to the year, accepting not one but three …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

